0.2642
Cue Biopharma Inc (CUE) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues |
27.25%
2.149
|
2.954 | 0.421 | 1.576 | 3.336 |
|
|
15.92%
9.744
|
11.59 | 12.72 | 11.21 | 12.15 |
| Benefits Costs and Expenses |
-
|
- | 12.68 | 11.07 | - |
| Costs And Expenses |
15.92%
9.744
|
11.59 | 12.68 | 11.07 | 12.15 |
| Provision For Loan, Lease, And Other Losses |
-
|
- | - | - | - |
| Depreciation and Amortization |
19.19%
0.08
|
0.099 | 0.101 | 0.098 | 0.101 |
| Operating Income/Loss |
12.04%
-7.595
|
-8.635 | -12.30 | -9.633 | -8.815 |
| Net Interest Income/Expense |
66.67%
-0.075
|
-0.045 | -0.128 | -0.153 | -0.188 |
| Nonoperating Income/Loss |
3.92%
0.147
|
0.153 | 0.042 | 0.137 | 0.155 |
| Income/Loss From Continuing Operations Before Tax |
27.25%
2.149
|
2.954 | -12.26 | -9.496 | 3.336 |
| Income/Loss From Continuing Operations After Tax |
12.19%
-7.448
|
-8.482 | -12.26 | -9.496 | -8.66 |
|
|
12.19%
-7.448
|
-8.482 | -12.26 | -9.496 | -8.66 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
5.67%
100.87
|
95.46 | 74.25 | 6.0354 | 51.23 |
| Diluted Average Shares |
5.67%
100.87
|
95.46 | 74.25 | 6.0354 | 51.23 |
| Basic Earnings Per Share |
22.22%
-0.07
|
-0.09 | -0.17 | -0.10 | -0.17 |
| Diluted Earnings Per Share |
22.22%
-0.07
|
-0.09 | -0.17 | -0.10 | -0.17 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):